Open AccessP1060: REAL‐WORLD CLINICAL OUTCOMES AFTER 3 AND 6 MONTHS OF TREATMENT WITH FEDRATINIB FOLLOWING RUXOLITINIB FAILURE
Author(s) -
Mascarenhas J.,
Gerds A. T.,
Kish J. K.,
Abraham P.,
Balanean A.,
Nadal J. A.,
Liassou D.,
Feinberg B. A.,
McBride A.,
Harrison C.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000847108.51760.ea
Subject(s) - medicine , ruxolitinib , myelofibrosis , white blood cell , anemia , spleen , gastroenterology , bone marrow